Barbara Doe

1.7k total citations
25 papers, 1.4k citations indexed

About

Barbara Doe is a scholar working on Immunology, Virology and Molecular Biology. According to data from OpenAlex, Barbara Doe has authored 25 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Immunology, 13 papers in Virology and 12 papers in Molecular Biology. Recurrent topics in Barbara Doe's work include HIV Research and Treatment (13 papers), Immunotherapy and Immune Responses (9 papers) and Immune Cell Function and Interaction (9 papers). Barbara Doe is often cited by papers focused on HIV Research and Treatment (13 papers), Immunotherapy and Immune Responses (9 papers) and Immune Cell Function and Interaction (9 papers). Barbara Doe collaborates with scholars based in United States, United Kingdom and Japan. Barbara Doe's co-authors include Mark Selby, Christopher M. Walker, Gillis R. Otten, Susan Barnett, Susan W. Barnett, Mary Schaefer, Jeffrey B. Ulmer, Jan zur Megede, Derek T. O’Hagan and Minchao Chen and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Virology.

In The Last Decade

Barbara Doe

25 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Barbara Doe United States 15 823 627 316 286 277 25 1.4k
J C Santoro United States 10 787 1.0× 529 0.8× 352 1.1× 406 1.4× 439 1.6× 12 1.5k
Minchao Chen United States 7 645 0.8× 507 0.8× 198 0.6× 266 0.9× 210 0.8× 9 1.1k
K Okuda Japan 24 862 1.0× 642 1.0× 279 0.9× 179 0.6× 261 0.9× 66 1.7k
Jan zur Megede United States 19 557 0.7× 377 0.6× 587 1.9× 359 1.3× 302 1.1× 32 1.1k
Jong J. Kim United States 24 963 1.2× 577 0.9× 298 0.9× 182 0.6× 414 1.5× 27 1.6k
Mark L. Bagarazzi United States 20 1.3k 1.6× 687 1.1× 621 2.0× 428 1.5× 585 2.1× 38 2.0k
M Francotte United States 13 481 0.6× 440 0.7× 660 2.1× 370 1.3× 514 1.9× 20 1.4k
Mary-Ellen Davies United States 16 772 0.9× 430 0.7× 540 1.7× 314 1.1× 589 2.1× 21 1.4k
Daniel E. McCallus United States 15 443 0.5× 435 0.7× 309 1.0× 128 0.4× 199 0.7× 18 966
Urs Hoffmann Rohrer Switzerland 9 993 1.2× 343 0.5× 152 0.5× 214 0.7× 324 1.2× 9 1.5k

Countries citing papers authored by Barbara Doe

Since Specialization
Citations

This map shows the geographic impact of Barbara Doe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara Doe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara Doe more than expected).

Fields of papers citing papers by Barbara Doe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barbara Doe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara Doe. The network helps show where Barbara Doe may publish in the future.

Co-authorship network of co-authors of Barbara Doe

This figure shows the co-authorship network connecting the top 25 collaborators of Barbara Doe. A scholar is included among the top collaborators of Barbara Doe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barbara Doe. Barbara Doe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Megede, Jan zur, Gillis R. Otten, Barbara Doe, et al.. (2006). Evaluation of human immunodeficiency virus type 1 subtype C gag, pol, and gagpol DNA and alphavirus replicon vaccines. Vaccine. 24(15). 2755–2763. 2 indexed citations
2.
Otten, Gillis R., Mary Schaefer, Barbara Doe, et al.. (2005). Enhanced Potency of Plasmid DNA Microparticle Human Immunodeficiency Virus Vaccines in Rhesus Macaques by Using a Priming-Boosting Regimen with Recombinant Proteins. Journal of Virology. 79(13). 8189–8200. 51 indexed citations
3.
Otten, Gillis R., Mary Schaefer, Barbara Doe, et al.. (2005). Potent immunogenicity of an HIV-1 gag–pol fusion DNA vaccine delivered by in vivo electroporation. Vaccine. 24(21). 4503–4509. 55 indexed citations
4.
Otten, Gillis R., Mary Schaefer, Barbara Doe, et al.. (2004). Enhancement of DNA vaccine potency in rhesus macaques by electroporation. Vaccine. 22(19). 2489–2493. 139 indexed citations
5.
Otten, Gillis R., Minchao Chen, Barbara Doe, et al.. (2003). Quantitative assessment of antigen-specific CD8+ T cells in the mouse: application to vaccine research. Immunology Letters. 85(2). 215–222. 3 indexed citations
6.
Megede, Jan zur, Gillis R. Otten, Barbara Doe, et al.. (2003). Expression and Immunogenicity of Sequence-Modified Human Immunodeficiency Virus Type 1 Subtype BpolandgagpolDNA Vaccines. Journal of Virology. 77(11). 6197–6207. 20 indexed citations
7.
Paliard, Xavier, Barbara Doe, M. J. Selby, et al.. (2001). Induction of Herpes Simplex Virus gB-Specific Cytotoxic T Lymphocytes in TAP1-Deficient Mice by Genetic Immunization but Not HSV Infection. Virology. 282(1). 56–64. 7 indexed citations
8.
O’Hagan, Derek T., Manmohan Singh, Mildred Ugozzoli, et al.. (2001). Induction of Potent Immune Responses by Cationic Microparticles with Adsorbed Human Immunodeficiency Virus DNA Vaccines. Journal of Virology. 75(19). 9037–9043. 141 indexed citations
9.
Denis-Mize, Kimberly, Marc Dupuis, Mary Lee MacKichan, et al.. (2000). Plasmid DNA adsorbed onto cationic microparticles mediates target gene expression and antigen presentation by dendritic cells. Gene Therapy. 7(24). 2105–2112. 130 indexed citations
10.
Otten, Gillis R., Barbara Doe, Mary Schaefer, et al.. (2000). Relative Potency of Cellular and Humoral Immune Responses Induced by DNA Vaccination. Intervirology. 43(4-6). 227–232. 22 indexed citations
11.
Megede, Jan zur, Minchao Chen, Barbara Doe, et al.. (2000). Increased Expression and Immunogenicity of Sequence-Modified Human Immunodeficiency Virus Type 1 gag Gene. Journal of Virology. 74(6). 2628–2635. 163 indexed citations
12.
Paliard, Xavier, Barbara Doe, & Christopher M. Walker. (1998). The T Cell Repertoire Primed by Antiviral Vaccination Is Influenced by Self-Tolerance. Cellular Immunology. 188(1). 73–79. 7 indexed citations
14.
Doe, Barbara, et al.. (1996). Induction of cytotoxic T lymphocytes by intramuscular immunization with plasmid DNA is facilitated by bone marrow-derived cells.. Proceedings of the National Academy of Sciences. 93(16). 8578–8583. 287 indexed citations
15.
Doe, Barbara, Kathelyn S. Steimer, & Christopher M. Walker. (1994). Induction of HIV‐1 envelope (gp120)‐specific cytotoxic T lymphocyte responses in mice by recombinant CHO cell‐derived gp120 is enhanced by enzymatic removal of N‐linked glycans. European Journal of Immunology. 24(10). 2369–2376. 45 indexed citations
16.
Doe, Barbara, et al.. (1991). HeLa-LAV, an epithelial cell line stably infected with HIV-1. Journal of Virological Methods. 34(2). 173–180. 11 indexed citations
17.
Chaignat, Claire‐Lise, Dietmar G. Braun, M Jeannet, et al.. (1991). Safety and Immunogenicity of a Genetically Engineered Human Immunodeficiency Virus Vaccine. The Journal of Infectious Diseases. 163(2). 219–225. 48 indexed citations
18.
Doe, Barbara, et al.. (1981). Affinity targeting of membrane vesicles to cell surfaces. Experimental Cell Research. 135(1). 137–145. 29 indexed citations
19.
Doe, Barbara, et al.. (1980). Fluorescence visualization of Ia antigens on T cells. Cellular Immunology. 53(1). 125–137. 6 indexed citations
20.
Cross, A, Andrew Davies, Barbara Doe, & E. Leuchars. (1964). Time of Action of the Thymus. Nature. 203(4951). 1239–1241. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026